Skip to main navigation Skip to search Skip to main content

89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging

  • Edmund J. Keliher
  • , Jeongsoo Yoo
  • , Matthias Nahrendorf
  • , Jason S. Lewis
  • , Brett Marinelli
  • , Andita Newton
  • , Mikael J. Pittet
  • , Ralph Weissleder
  • Massachusetts General Hospital
  • Memorial Sloan-Kettering Cancer Center
  • Harvard University

Research output: Contribution to journalArticlepeer-review

135 Scopus citations

Abstract

Tissue macrophages play a critical role both in normal physiology and in disease states. However, because of a lack of specific imaging agents, we continue to have a poor understanding of their absolute numbers, flux rates, and functional states in different tissues. Here, we describe a new macrophage specific positron emission tomography imaging agent, labeled with zirconium-89 (89Zr), that was based on a cross-linked, short chain dextran nanoparticle (13 nm). Following systemic administration, the particle demonstrated a vascular half-life of 3.9 h and was found to be located primarily in tissue resident macrophages rather than other white blood cells. Subsequent imaging of the probe using a xenograft mouse model of cancer allowed for quantitation of tumor-associated macrophage numbers, which are of major interest in emerging molecular targeting strategies. It is likely that the material described, which allows the visualization of macrophage biology in vivo, will likewise be useful for a multitude of human applications.

Original languageEnglish
Pages (from-to)2383-2389
Number of pages7
JournalBioconjugate Chemistry
Volume22
Issue number12
DOIs
StatePublished - 21 Dec 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of '89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging'. Together they form a unique fingerprint.

Cite this